Literature DB >> 1642825

Methylphenidate in stroke patients with depression.

M L Johnson1, M D Roberts, A R Ross, C M Witten.   

Abstract

The treatment of depression after stroke is a difficult clinical problem. Many of the medications used to treat patients with depression in the general population have significant potential side effects that are of particular concern in elderly patients. We reviewed the records of ten patients with stroke treated with methylphenidate for depression during an inpatient rehabilitation program. Improvement was noted in seven patients. This suggests that methylphenidate in the treatment of post-stroke depression merits further study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642825     DOI: 10.1097/00002060-199208000-00008

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  4 in total

Review 1.  Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

Authors:  Susan E Hardy
Journal:  Am J Geriatr Pharmacother       Date:  2009-02

Review 2.  Epidemiology and treatment of post-stroke depression.

Authors:  Y Gustafson; I Nilsson; M Mattsson; M Aström; G Bucht
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

3.  Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study.

Authors:  Rajamannar Ramasubbu; Bradley G Goodyear
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

Review 4.  Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis.

Authors:  Chi-Hsien Huang; Chia-Chen Huang; Cheuk-Kwan Sun; Gong-Hong Lin; Wen-Hsuan Hou
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.